My experience involves really well funded research areas in e.g. Oxbridge, sometimes better funded than their US counterparts I have interacted with. So I don't think its only about funding, but how funding is allocated. EU funding has a winner-takes-it-all structure. A few groups get enormous grants and the rest get nothing. Ironically, these groups have questionable productivity. Whereas in the US, e.g. NIH has lots of small and mid-sized grants that are suitable for a junior academic.
Junior faculty openings also exhibit the same trend and are much more common in the US. Among all people I have met in EU Academia throughout these years, only one person managed to progress to a faculty position. All others left Academia. Quite brutal, that figure should give policymakers some pause. In contrast, I know a few US academics that moved from PhD student to assistant and associate professor positions.
Exploiting postdocs without any promotion opportunities in sight is so common in EU that many countries are passing, or have already passed, laws to limit postdoc length. However, without more junior faculty openings and permanent staff scientist positions, I am not sure how this is going to work out.
Junior faculty openings also exhibit the same trend and are much more common in the US. Among all people I have met in EU Academia throughout these years, only one person managed to progress to a faculty position. All others left Academia. Quite brutal, that figure should give policymakers some pause. In contrast, I know a few US academics that moved from PhD student to assistant and associate professor positions.
Exploiting postdocs without any promotion opportunities in sight is so common in EU that many countries are passing, or have already passed, laws to limit postdoc length. However, without more junior faculty openings and permanent staff scientist positions, I am not sure how this is going to work out.